Hydroxychloroquine might reduce mortality in patients with systemic sclerosis

被引：1
|
作者：
Otman, Eda [1 ]
Gucenmez, Sercan [1 ]
Solmaz, Dilek [1 ]
Akar, Servet [1 ]
Ozmen, Mustafa [1 ]
机构：
[1] Izmir Katip Celebi Univ, Ataturk Educ & Res Hosp, Div Rheumatol, Dept Internal Med, Izmir, Turkiye
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2023年 / 26卷 / 08期
关键词：
hydroxychloroquine; mortality; predictors; scleroderma; systemic sclerosis;
D O I：
10.1111/1756-185X.14670
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1640 / 1642
页数：3
相关论文
共 50 条
  • [41] Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis
    Abdin, A.
    Poess, J.
    Reil, J.
    Fuernau, G.
    Kandolf, R.
    Thiele, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 303 - 303
  • [42] Hydroxychloroquine in pregnant patients with systemic lupus erythematosus
    Parke, A
    West, B
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (10) : 1715 - 1718
  • [43] Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis
    Amr Abdin
    Janine Pöss
    Reinhard Kandolf
    Holger Thiele
    Clinical Research in Cardiology, 2017, 106 : 234 - 236
  • [44] USE OF IPRATROPIUM AND SALMETEROL MIGHT REDUCE THE RISK OF MULTIPLE SCLEROSIS (MS)
    Ren, J.
    Ascenico, M.
    Raimondi, T.
    Rainville, E.
    Valenzuela, R.
    Asche, C., V
    VALUE IN HEALTH, 2019, 22 : S280 - S280
  • [45] UPPER GASTROINTESTINAL BLEEDING IS ASSOCIATED WITH SIGNIFICANTLY HIGHER MORTALITY IN SYSTEMIC SCLEROSIS PATIENTS
    Braun-Moscovici, Y.
    Markovits, D.
    Gralnek, I.
    Toledano, K.
    Beshara-Garzoz, R.
    Dagan, A.
    Rozin, A.
    Chowers, Y.
    Balbir-Gurman, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 571 - 572
  • [46] Predictors of early mortality in systemic sclerosis: a case–control study comparing early versus late mortality in systemic sclerosis
    Chris T. Derk
    Gonzalo Huaman
    Jayne Littlejohn
    Franklin Otieno
    Sergio Jimenez
    Rheumatology International, 2012, 32 : 3841 - 3844
  • [47] Cardiac MRI in Systemic Sclerosis As Prognostic Tool of Cardiac Mortality in Symptomatic Patients
    Bosello, Silvia
    Canestrari, Giovanni
    De Lorenzis, Enrico
    Natalello, Gerlando
    Parisi, Federico
    Meduri, Agostino
    Marano, Riccardo
    Ferraccioli, Gianfranco
    Gremese, Elisa
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [48] CARDIAC INVOLVEMENT AND MORTALITY IN SYSTEMIC-SCLEROSIS (SCLERODERMA) - A STUDY OF 35 PATIENTS
    ALVAREZ, B
    SANCHEZ, S
    POVEDA, J
    RODRIGUEZVALVERDE, V
    ALONSO, J
    DELAHERA, M
    MEDICINA CLINICA, 1988, 91 (16): : 601 - 604
  • [49] Hospitalizations and in-hospital mortality in patients with systemic sclerosis in the United States.
    Chung, Lorinda
    Krishnan, Eswar
    Friedman, Gary D.
    Chakravarty, Eliza F.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4075 - 4076
  • [50] COVID-19: Does Azithromycin plus Hydroxychloroquine reduce the Mortality Rate?
    Metzger, Leandra
    PNEUMOLOGIE, 2022, 76 (06): : 389 - 389
12345